A new student is joining Adrian Woolf’s team at University of Manchester, her name is Filipa Lopes (ESR 7) and she is from Portugal:
“I am Filipa, from Vila Real, a lovely city in the North of Portugal.
I have a first degree in Biology, concluded in 2012 at the University of Trás-os.-Montes e Alto Douro, Vila Real, Portugal. During the last semester I worked as a research trainee in the Biochemistry and Biology & Bioenergetics labs. This work involved the production of polysaccharides from Ganoderma resinaceum and evaluation of its effects in colon and liver cancer cell lines. In the same year, I moved to Porto, Portugal, where I studied for my master’s degree in Oncology- specialization in Molecular Oncology at the Abel Salazar Institute of Biomedical Sciences of the University of Porto (ICBAS/UP) & The Portuguese Oncology Institute – Porto, Portugal. In order to carry out my dissertation, I joined the Cancer Genetics group at Institute of Molecular Pathology and Immunology at the University of Porto (IPATIMUP) integrating the I3S consortium, within Dr Joana Paredes’s Team. The project addressed the study of molecular mechanisms by which P-cadherin, a cell adhesion molecule, an established breast cancer stem cell biomarker, confers chemo- and radiotherapy cell death resistance, with a focus on the DNA Damage Repair pathway.
It is with great pleasure that I am joining to the EU Horizon 2020 Marie Skłodowska-Curie Innovative Training Network Project RENALTRACT. As ESR 7 at The University of Manchester, I will work in a project with the aim of highlight novel neurological perspectives on congenital tract urinary disease, a pathology that severely compromises the quality of life in affected children.”